These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22977850)

  • 21. Excretion of afobazole and its metabolites with urine and feces in rats.
    Viglinskaya AO; Kolyvanov GB; Litvin AA; Zherdev VP; Seredenin SB
    Bull Exp Biol Med; 2008 Apr; 145(4):440-2. PubMed ID: 19110588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetic study of 2-(N-benzylamino)adamatane (bemantan) by a gas-liquid chromatographic method].
    Liubimov BI; Skoldinov AP; Boĭko SS; Rodionov AP; Mozhaeva TIa
    Farmakol Toksikol; 1980; 43(4):408-11. PubMed ID: 7439377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition and biotransformation of the estrogenic isoflavone daidzein in rats.
    Bayer T; Colnot T; Dekant W
    Toxicol Sci; 2001 Aug; 62(2):205-11. PubMed ID: 11452132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of berberine and its metabolites in oral administration in rats.
    Ma JY; Feng R; Tan XS; Ma C; Shou JW; Fu J; Huang M; He CY; Chen SN; Zhao ZX; He WY; Wang Y; Jiang JD
    J Pharm Sci; 2013 Nov; 102(11):4181-92. PubMed ID: 24006193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans.
    Nakada N; Oda K
    Xenobiotica; 2015; 45(9):757-65. PubMed ID: 25869242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single dose mass balance study of the Hedgehog pathway inhibitor vismodegib (GDC-0449) in humans using accelerator mass spectrometry.
    Graham RA; Lum BL; Morrison G; Chang I; Jorga K; Dean B; Shin YG; Yue Q; Mulder T; Malhi V; Xie M; Low JA; Hop CE
    Drug Metab Dispos; 2011 Aug; 39(8):1460-7. PubMed ID: 21602311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The possibilities of using himantane in the treatment of Parkinson's disease].
    Katunina EA; Petrukhova AV; Avakian GN; Val'dman EA; Nerobkova LN; Voronina TA; Saiadian KhS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):24-7. PubMed ID: 18577930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.
    Lennernäs H; Renberg L; Hoffmann KJ; Regårdh CG
    Drug Metab Dispos; 1993; 21(3):435-40. PubMed ID: 8100498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acrylonitrile-14C metabolism in rats: effect of the route of administration on the elimination of thiocyanate and other radioactive metabolites in urine and feces.
    Gut I; Kopecký J; Filip J
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):12-6. PubMed ID: 7229351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pharmacokinetics and metabolism of propiverine in man.
    Haustein KO; Hüller G
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):81-90. PubMed ID: 3208795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats.
    Kim J; Wang R; Veverka KA; Dalton JT
    Xenobiotica; 2013 Nov; 43(11):993-1009. PubMed ID: 24074268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring in vivo metabolism and excretion of QO-58L using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Zhang J; Jia Q; Qi J; Zhang H; Wu Y; Shi X
    Eur J Pharm Sci; 2018 May; 117():379-391. PubMed ID: 29452212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans.
    He H; Tran P; Yin H; Smith H; Batard Y; Wang L; Einolf H; Gu H; Mangold JB; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):536-44. PubMed ID: 19074975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adamantane derivate enhances cerebral blood flow under conditions of ischemic brain damage].
    Mirzoian RS; Gan'shina TS; Maslennikov DV; Turilova AI; Avdiunina NI; Piatin BM
    Eksp Klin Farmakol; 2012; 75(6):27-30. PubMed ID: 22891438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans.
    Vincent SH; Reed JR; Bergman AJ; Elmore CS; Zhu B; Xu S; Ebel D; Larson P; Zeng W; Chen L; Dilzer S; Lasseter K; Gottesdiener K; Wagner JA; Herman GA
    Drug Metab Dispos; 2007 Apr; 35(4):533-8. PubMed ID: 17220239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolism of methiothepin in the rat, dog and man].
    Eschenhof E; Meister W; Oesterhelt G; Vetter W
    Arzneimittelforschung; 1976 Feb; 26(2):262-71. PubMed ID: 947211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.